Octreotide-Induced Asystolic Events in a Patient after Pancreatoduodenectomy

Octreotide, a somatostatin analog, has been used after pancreatic surgery to reduce complications. We report a case of a patient who experienced an asystolic event because of a subcutaneous octreotide injection, post pancreatoduodenectomy. Although octreotide leading to bradycardia and heart block has been documented in several reports, an octreotide induced asystole case is very rare. To our knowledge, this is the first case of subcutaneously injected octreotide leading to asystole.